Has Mohamad Azzam, MD received payments from drug or device companies?

Yes. Drug and device makers reported $51,183 in general payments to Mohamad Azzam, MD across 309 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mohamad Azzam, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mohamad Azzam, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mohamad Azzam, MD

Pain Medicine · Webster, TXNPI 1144517467

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $31,825 of the $51,183 with a category attached, or 62.2%. Boston Scientific accounts for 88.0% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2022 at $14,733 and has fallen 97.0% since, to $439 in 2025. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$51,183in general payments, 2019–2025

Across 309 payments — averaging $165.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$45K
MML US, Inc.$2K
Spinal Simplicity, LLC$2K
Painteq LLC$869
Nalu Medical, Inc.$488
Saluda Medical Americas, Inc.$335
plus $1K from 20 others

What the payments were for

Consulting fees$5,21310%
Speaking & faculty fees$31,82562%
Travel & lodging$6,65413%
Food & beverage$6,21312%
Education$1,2792%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	190	$45,036
MML US, Inc.	10	$1,777
Spinal Simplicity, LLC	2	$1,647
Painteq LLC	33	$869
Nalu Medical, Inc.	17	$488
Saluda Medical Americas, Inc.	10	$335
Abbott	20	$286
Vertos Medical, Inc.	3	$174
Relievant Medsystems, Inc.	1	$95
Vertex	2	$50
Nevro Corp.	2	$45
AbbVie	2	$42
Fujifilm Sonosite, Inc.	1	$41
Medtronic(2 entities)	2	$40
Collegium Pharmaceutical, Inc.	2	$38
Bioventus LLC	2	$35
Lundbeck LLC	1	$24
Averitas Pharma Inc.	1	$24
Fisher & Paykel Healthcare Inc	1	$23
Amgen	1	$18
Zyla Life Sciences, Inc.	1	$18
Foundation Fusion Solutions, LLC	1	$18
Novartis	1	$17
Biodelivery Sciences International, Inc.	1	$15
Promius Pharma LLC	1	$14
Assertio Therapeutics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,183 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$585,022

Medicare patients

786

Services billed

9,339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	1,004	$12,814
Buprenorphine	26	$7,686
Pregabalin	316	$3,852
Gabapentin	542	$3,141
MovantikNaloxegol Oxalate	12	$3,086
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	266	$2,499
OxycontinOxycodone Hcl	22	$2,075
Acetaminophen-CodeineAcetaminophen With Codeine	161	$1,748
Methocarbamol	479	$1,730
Tramadol Hcl	205	$1,235
Oxycodone Hcl	186	$976
Fentanyl	21	$932
Cyclobenzaprine Hcl	111	$633
Tizanidine Hcl	80	$373
Duloxetine Hcl	22	$363

Paid to pharmacies, not to this prescriber.

Other pain medicine in Webster

Eduardo GarciaWebster$147K
Steven CannellaWebster$28K
Joseph Toothaker AlvarezWebster$23K
Melissa MurphyGrapevine$653K
Shiraz YazdaniLubbock$514K
Aaron CalodneyTyler$296K
Candice BurnetteSugar Land$265K
Ashley Bailey-ClassenFort Worth$244K
Grant ChenHouston$175K
Gunjan PatelHouston$166K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →